Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-10
DOI
10.1038/s41598-019-49140-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle
- (2016) Tahnee L. Kennedy et al. AMERICAN JOURNAL OF PATHOLOGY
- Glycine restores the anabolic response to leucine in a mouse model of acute inflammation
- (2016) Daniel J. Ham et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glycine supplementation during calorie restriction accelerates fat loss and protects against further muscle loss in obese mice
- (2016) Marissa K. Caldow et al. CLINICAL NUTRITION
- Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program
- (2015) Alexander Morrison-Nozik et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy
- (2015) Christian Giordano et al. HUMAN MOLECULAR GENETICS
- Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical Trials
- (2014) J. N. Kornegay et al. ILAR JOURNAL
- 6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes
- (2014) Marika Pane et al. PLoS One
- Prednisolone Attenuates Improvement of Cardiac and Skeletal Contractile Function and Histopathology by Lisinopril and Spironolactone in the mdx Mouse Model of Duchenne Muscular Dystrophy
- (2014) Paul M. L. Janssen et al. PLoS One
- Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia
- (2013) Daniel J. Ham et al. CLINICAL NUTRITION
- VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
- (2013) Christopher R. Heier et al. EMBO Molecular Medicine
- Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?
- (2013) Pura Muñoz-Cánoves et al. FEBS Journal
- Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia
- (2012) K. T. Murphy et al. Disease Models & Mechanisms
- Motor performance of young dystrophic mdx mice treated with long-circulating prednisolone liposomes
- (2012) Charlotte Weller et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Hsp72 preserves muscle function and slows progression of severe muscular dystrophy
- (2012) Stefan M. Gehrig et al. NATURE
- Inflammation-induced decrease in voluntary wheel running in mice: A nonreflexive test for evaluating inflammatory pain and analgesia
- (2012) Enrique J. Cobos et al. PAIN
- Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair
- (2011) Haiyan Lu et al. FASEB JOURNAL
- Monosodium iodoacetate-induced osteoarthritis produces pain-depressed wheel running in rats: Implications for preclinical behavioral assessment of chronic pain
- (2010) Glenn W. Stevenson et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Making Fast-Twitch Dystrophic Muscles Bigger Protects Them from Contraction Injury and Attenuates the Dystrophic Pathology
- (2009) Stefan M. Gehrig et al. AMERICAN JOURNAL OF PATHOLOGY
- Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
- (2009) Katharine Bushby et al. LANCET NEUROLOGY
- Effects of prednisolone on skeletal muscle contractility inmdxmice
- (2009) Kristen A. Baltgalvis et al. MUSCLE & NERVE
- Preclinical drug trials in themdxmouse: Assessment of reliable and sensitive outcome measures
- (2009) Christopher F. Spurney et al. MUSCLE & NERVE
- Insulin-like growth factor-I analogue protects muscles of dystrophicmdxmice from contraction-mediated damage
- (2008) Stefan M. Gehrig et al. EXPERIMENTAL PHYSIOLOGY
- Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy
- (2008) M. Wehling-Henricks et al. HUMAN MOLECULAR GENETICS
- Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment
- (2008) Hannah G. Radley et al. NEUROMUSCULAR DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now